MAPT and Alzheimer disease: This study highlights the importance of alternative disease mechanisms to understand the origin of temporal change of AD biomarkers in blood, as the manifestation and fluctuations of p-tau and Aβ in the bloodstream were not solely associated with Aβ plaques and neurofibrillary tau tangles.